Successful pediatric liver transplantation case with a positive SARS-CoV-2 test at the time of transplant.

SARS-CoV-2 infection antiviral treatment pediatric liver transplantation

Journal

Hepatology research : the official journal of the Japan Society of Hepatology
ISSN: 1386-6346
Titre abrégé: Hepatol Res
Pays: Netherlands
ID NLM: 9711801

Informations de publication

Date de publication:
Jun 2023
Historique:
revised: 14 12 2022
received: 10 08 2022
accepted: 12 01 2023
medline: 20 1 2023
pubmed: 20 1 2023
entrez: 19 1 2023
Statut: ppublish

Résumé

We report a successful liver transplantation (LT) in a child with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. A 3-year-old female patient with decompensated cirrhosis due to Alagille syndrome underwent a split LT with a left lateral segment graft. She had a history of SARS-CoV-2 infection 4 months before LT. She was exposed to SARS-CoV-2 after the decision for organ acceptance. We repeatedly confirmed the negative SARS-CoV-2 test by polymerase chain reaction (PCR) before LT. Liver transplantation was carried out in the negative pressure operational theater with full airborne, droplet, and contact precautions as the patient was considered to be within the incubation period of SARS-CoV-2. The SARS-CoV-2 PCR test became positive in the nasopharyngeal swab specimen at the operation. Remdesivir, the antiviral treatment, was held off due to potential hepatotoxicity and no exacerbation of COVID-19. She received tacrolimus and low-dose steroids per protocol. She remained SARS-CoV-2 positive on postoperative days (PODs) 1, 2, and 5. The presence of antibodies for SARS-CoV-2 at LT was confirmed later. On POD 53, she was discharged without any symptomatic infection. This case demonstrated that a positive SARS-CoV-2 result was not an absolute contraindication for a life-saving LT. Liver transplantation could be safely performed in a pediatric patient with asymptomatic COVID-19 and S-immunoglobulin G antibodies for SARS-CoV-2.

Identifiants

pubmed: 36654476
doi: 10.1111/hepr.13881
doi:

Types de publication

Case Reports

Langues

eng

Pagination

569-573

Subventions

Organisme : Scientific Research Fund of the Ministry of Education and a Research Grant for Immunology, Allergy and Organ Transplant, Labor and Welfare, Japan
ID : 21591403, R3-1
Organisme : JSPS KAKENHI
ID : JP21K16392

Informations de copyright

© 2023 Japan Society of Hepatology.

Références

Ritschl PV, Nevermann N, Wiering L, Wu HH, Moroder P, Brandl A, et al. Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: a By-proxy Society Recommendation Consensus approach. Am J Transplant. 2020;20(7):1826-36. https://doi.org/10.1111/ajt.15933
Corey L, Beyrer C, Cohen MS, Michael NL, Bedford T, Rolland M. SARS-CoV-2 variants in patients with immunosuppression. N Engl J Med. 2021;385(6):562-6. https://doi.org/10.1056/nejmsb2104756
Stock PG, Wall A, Gardner J, Dominguez-Gil B, Chadban S, Muller E, et al. Ethical issues in the COVID era: doing the right thing depends on location, resources, and disease burden. Transplantation. 2020;104(7):1316-20. https://doi.org/10.1097/tp.0000000000003291
Bhattacharyya RP, Hanage WP. Challenges in inferring intrinsic severity of the SARS-CoV-2 Omicron variant. N Engl J Med. 2022;386(7):e14. https://doi.org/10.1056/nejmp2119682
Kasahara M, Sakamoto S, Fukuda A. Pediatric living-donor liver transplantation. Semin Pediatr Surg. 2017;26(4):224-32. https://doi.org/10.1053/j.sempedsurg.2017.07.008
Yamada M, Funaki T, Shoji K, Miyairi I, Fukuda A, Sakamoto S, et al. Do not delay: safe operation for pediatric living-donor liver transplantation programs in the COVID-19 era. Transplantation. 2021;105(3):e39-40. https://doi.org/10.1097/tp.0000000000003594
Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A, Jacob M, et al. Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI). Hepatol Int. 2020;14(4):429-31. https://doi.org/10.1007/s12072-020-10041-1
Clinical best practice advice for Hepatology and liver transplant providers during the Covid-19 pandemic: aasld expert panel consensus statement. 2021.
Yohanathan L, Campioli CC, Mousa OY, Watt K, Friedman DZP, Shah V, et al. Liver transplantation for acute liver failure in a SARS-CoV-2 PCR-positive patient. Am J Transplant. 2021;21(8):2890-4. https://doi.org/10.1111/ajt.16582
LiverTox: clinical and research information on drug-induced liver Injury. 2022 Bethesda: National Institute of Diabetes and Digestive and Kidney Diseases:2012. Remdesivir.
D’Antiga L. Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transpl. 2020;26(6):832-4. https://doi.org/10.1002/lt.25756
Fazolo T, Lima K, Fontoura JC, de Souza PO, Hilario G, Zorzetto R, et al. Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific antiviral responses. Nat Commun. 2021;12(1):6844. https://doi.org/10.1038/s41467-021-27120-y
Peterhoff D, Gluck V, Vogel M, Schuster P, Schutz A, Neubert P, et al. A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization. Infection. 2021;49(1):75-82. https://doi.org/10.1007/s15010-020-01503-7
Dolscheid-Pommerich R, Bartok E, Renn M, Kummerer BM, Schulte B, Schmithausen RM, et al. Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity. J Med Virol. 2022;94(1):388-92. https://doi.org/10.1002/jmv.27287
Manzia TM, Gazia C, Lenci I, Angelico R, Toti L, Monaco A, et al. Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor. Am J Transplant. 2021;21(7):2600-4. https://doi.org/10.1111/ajt.16548
Rouphael C, D’Amico G, Ricci K, Cywinski J, Miranda C, Koval C, et al. Successful orthotopic liver transplantation in a patient with a positive SARS-CoV2 test and acute liver failure secondary to acetaminophen overdose. Am J Transplant. 2021;21(3):1312-16. https://doi.org/10.1111/ajt.16330
Mouch CA, Alexopoulos SP, LaRue RW, Kim HP. Successful liver transplantation in patients with active SARS-CoV-2 infection. Am J Transplant. 2022.
Shrwani K, Sharma R, Krishnan M, Jones T, Mayora-Neto M, Cantoni D, et al. Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in prepandemic and post-COVID-19 convalescent samples. J Infect Dis. 2021;224(8):1305-15. https://doi.org/10.1093/infdis/jiab333

Auteurs

Seiichi Shimizu (S)

Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.

Seisuke Sakamoto (S)

Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.

Masaki Yamada (M)

Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
Department of Advanced Medicine for Viral Infections, National Center for Child Health and Development, Tokyo, Japan.

Takanori Funaki (T)

Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.

Akinari Fukuda (A)

Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.

Hajime Uchida (H)

Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.

Noriki Okada (N)

Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.

Toshimasa Nakao (T)

Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.

Tasuku Kodama (T)

Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.

Ryuji Komine (R)

Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.

Kensuke Shoji (K)

Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.

Chiaki Baba (C)

Department of Anesthesia and Intensive Care, National Center for Child Health and Development, Tokyo, Japan.

Yasuyuki Suzuki (Y)

Department of Anesthesia and Intensive Care, National Center for Child Health and Development, Tokyo, Japan.

Satoshi Nakagawa (S)

Critical Care Medicine, National Center for Child Health and Development, Tokyo, Japan.

Chikara Ogimi (C)

Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.

Mureo Kasahara (M)

Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.

Classifications MeSH